观察血液透析患者肾性贫血采取促红细胞生长素联合蔗糖铁治疗的临床效果

摘要

目的：观察血液透析患者肾性贫血采取促红细胞生长素联合蔗糖铁治疗的临床效果。方法选取我院自2014年10月～2015年10月收治的40例血液透析患者作为观察对象，对其实施促红细胞生长素联合蔗糖铁治疗。检测并记录患者治疗前、治疗3个月后的红细胞压积（HCT）、血红蛋白（Hb）、转铁饱和度（TSAT）以及血清铁蛋白（SF）等临床指标。结果与治疗前相比，治疗3个月患者血液中HCT、Hb、TSAT以及SF的临床指标均得以提高（P＜0.05），表明患者的贫血得到改善。结论针对血液透析患者肾性贫血，采取促红细胞生长素联合蔗糖铁治疗，可显著提升患者HCT、Hb、TSAT以及SF指标。%Objective To observe the clinical effect of the treatment of renal anemia with erythropoietin combined with sucrose iron in hemodialysis patients.Methods 40 cases of hemodialysis patients treated in our hospital from October 2014 to October 2015 were selected as the observation object. Detection and recording of patients before treatment,3 months after the treatment of red blood cell pressure(HCT),hemoglobin(Hb), transferrin saturation(TSAT) and serum ferritin(SF)and other clinical indicators.Results Compared with before treatment,the clinical parameters of HCT,Hb,TSAT and SF in the blood of 3 months were improved(P<0.05),which showed that the anemia was improved. Conclusion In the hemodialysis patients with renal anemia,erythropoietin combined with sucrose iron treatment,can significantly improve the patients with HCT,Hb,TSAT and SF indicators.